Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$0.27 USD
-0.01 (-3.23%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $0.27 0.00 (-1.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.23 | 18.57% |
Earnings Summary
For their last quarter, Lyra Therapeutics (LYRA) reported earnings of -$0.29 per share, beating the Zacks Consensus Estimate of $-0.34 per share. This reflects a positive earnings surprise of 14.71%. Look out for LYRA's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 14.81%.
Earnings History
Price & Consensus
Zacks News for LYRA
Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
LYRA: What are Zacks experts saying now?
Zacks Private Portfolio Services